Samsung Biologics to launch takeover bid for PolyPeptide in September
Samsung Biologics to launch takeover bid for PolyPeptide in September Reuters
Finance, IT & News
Samsung Biologics to launch takeover bid for PolyPeptide in September Reuters
NGFA Says No to Proposed Railroad Merger KMAland.com
Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases PR Newswire
Teva Pharmaceuticals to acquire BioXcel assets for up to $125m Pharmaceutical Technology
Ukraine’s Defense Forces strike Russian radar, S-400 command-and-staff vehicle and supply depots Ukrinform